Key statistics
As of last trade, Elevation Oncology Inc (ELEV:NSQ) traded at 0.5877, 61.90% above the 52 week low of 0.363 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.5956 |
---|---|
High | 0.6185 |
Low | 0.58 |
Bid | 0.58 |
Offer | 0.5877 |
Previous close | 0.5998 |
Average volume | 588.93k |
---|---|
Shares outstanding | 59.11m |
Free float | 56.93m |
P/E (TTM) | -- |
Market cap | 35.45m USD |
EPS (TTM) | -0.8399 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 17:22 BST.
More ▼
- Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements
- Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2
- Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer